Bernardo Wealth Planning’s Antares Pharma, Inc. ATRS Stock Holding History

Bernardo Wealth Planning’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26,075	Closed	-$104K	–	174
2020 Q4	$104K	Hold	26,075	–	–	0.04%	170
2020 Q3	$70K	Hold	26,075	–	–	0.03%	156
2020 Q2	$71K	Hold	26,075	–	–	0.04%	139
2020 Q1	$61K	Sell	26,075 -50	-0.2%	-$170	0.04%	131
2019 Q4	$122K	Sell	26,125 -29,314	-53%	-$120K	0.07%	163
2019 Q3	$185K	Hold	55,439	–	–	0.13%	153
2019 Q2	$182K	Hold	55,439	–	–	0.14%	144
2019 Q1	$168K	Hold	55,439	–	–	0.13%	143
2018 Q4	$151K	Buy	+55,439	New	+$183K	0.13%	127

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Bernardo Wealth Planning's ATRS Position: Q1 2021 in Review

Bernardo Wealth Planning sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 26,075 shares — an estimated $104K sold.

Bernardo Wealth Planning first reported a position in ATRS in Q4 2018 and held it in 9 quarters. The position peaked at $185K in Q3 2019. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

Bernardo Wealth Planning reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
Bernardo Wealth Planning sold 26,075 Antares Pharma, Inc. shares in Q1 2021, an estimated $104K.
Bernardo Wealth Planning first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 9 quarters.
Bernardo Wealth Planning's Antares Pharma, Inc. position peaked at $185K in Q3 2019.
171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Bernardo Wealth Planning's 13F filing for Q1 2021, filed 23 Apr 2021.